Ligand(LGND) - 2024 Q4 - Earnings Call Transcript

Ligand Pharmaceuticals (LGND) Q4 2024 Earnings Call February 27, 2025 08:30 AM ET Company Participants Melanie Herman - Executive Director - Investor Relations and FP&ATodd Davis - CEOPaul Hadden - Senior Vice President of Investments & Business DevelopmentTavo Espinoza - CFOLauren Hay - Vice President - Strategic Planning & Investment Analytics Conference Call Participants Matt Hewitt - Senior Research AnalystJoseph Pantginis - MD & Senior Healthcare AnalystDouglas Miehm - AnalystTrevor Allred - Biotech An ...